{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:02:04Z","timestamp":1767841324834,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000046","name":"National Research Council Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.virol.2023.07.009","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T07:40:46Z","timestamp":1689752446000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Protease-deleted adenovirus as an alternative for replication-competent adenovirus vector"],"prefix":"10.1016","volume":"586","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2040-5665","authenticated-orcid":false,"given":"S. Mehdy","family":"Elahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazila","family":"Nazemi-Moghaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9nald","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2023.07.009_bib1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fonc.2019.01182","article-title":"Oncolytic adenovirus-A nova for gene-targeted oncolytic viral therapy in HCC","volume":"9","author":"Abudoureyimu","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.virol.2023.07.009_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/hmg\/3.4.579","article-title":"A differential efficiency of an adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity","volume":"3","author":"Acsadi","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.virol.2023.07.009_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncrna.2018.11.005","article-title":"Modifying inter-cistronic sequence significantly enhances IRES dependent second gene expression in bicistronic vector: construction of optimised cassette for gene therapy of familial hypercholesterolemia","volume":"4","author":"Al-Allaf","year":"2018","journal-title":"Non-Coding RNA Res."},{"key":"10.1016\/j.virol.2023.07.009_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/hum.1995.6.10-1343","article-title":"Characterization of an adenovirus gene transfer vector containing an E4 deletion","volume":"6","author":"Armentano","year":"1995","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virol.2023.07.009_bib5","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1128\/jvi.71.3.2408-2416.1997","article-title":"Effect of the E4 region on the persistence of transgene expression from adenovirus vectors","volume":"71","author":"Armentano","year":"1997","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2023.07.009_bib6","first-page":"163","article-title":"Single-cycle adenovirus vectors in the current vaccine landscape","volume":"17","author":"Barry","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2023.07.009_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/abio.2002.5706","article-title":"A noninvasive cell-based assay for monitoring proteolytic activity within a specific subcellular compartment","volume":"306","author":"Belkhiri","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.virol.2023.07.009_bib8","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1158\/0008-5472.CAN-06-4317","article-title":"Improvement of antitumor activity by gene amplification with a replicating but nondisseminating adenovirus","volume":"67","author":"Bourbeau","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2023.07.009_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/hum.1996.7.3-333","article-title":"Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active Interleukin-12","volume":"7","author":"Bramson","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virol.2023.07.009_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/jvi.63.2.631-638.1989","article-title":"Redundant control of adenovirus late gene expression by early region 4","volume":"63","author":"Bridge","year":"1989","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2023.07.009_bib11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/viro.1995.0022","article-title":"The adenovirus protease is required for virus entry into host cells","volume":"213","author":"Cotten","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.07.009_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.virol.2014.05.030","article-title":"IIIa deleted adenovirus as a single-cycle genome replicating vector","volume":"462\u2013463","author":"Crosby","year":"2014","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2023.07.009_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/genes8020079","article-title":"Transgene expression and host cell responses to replication-defective, single-cycle, and replication-competent adenovirus vectors","volume":"8","author":"Crosby","year":"2017","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.virol.2023.07.009_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00720-16","article-title":"Replicating single-cycle adenovirus vectors generate amplified Influenza vaccine responses","volume":"91","author":"Crosby","year":"2017","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2023.07.009_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1128\/JVI.02184-14","article-title":"Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines","volume":"89","author":"Crosby","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.07.009_bib16","first-page":"28","author":"Castagner","year":"2002"},{"issue":"6","key":"10.1016\/j.virol.2023.07.009_bib17","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/jvi.67.6.3507-3514.1993","article-title":"The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells","volume":"67","author":"Chen","year":"1993","journal-title":"J. Virol."},{"issue":"20","key":"10.1016\/j.virol.2023.07.009_bib18","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.gt.3301301","article-title":"Production of first generation adenovirus vectors: a review","volume":"7","author":"Danthinne","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.virol.2023.07.009_bib19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/sj.gt.3301793","article-title":"Adenovirus-based libraries: efficient generation of recombinant adenoviruses by positive selection with the adenovirus protease","volume":"18","author":"Elahi","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.virol.2023.07.009_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114267","article-title":"A rapid Focus-Forming Assay for quantification of infectious adenoviral vectors","volume":"297","author":"Elahi","year":"2021","journal-title":"J. Virol. Methods"},{"issue":"4","key":"10.1016\/j.virol.2023.07.009_bib21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/cells12040619","article-title":"Complementary cell lines for protease gene-deleted single-cycle adenovirus vectors","volume":"12","author":"Elahi","year":"2023","journal-title":"Cells"},{"issue":"Pt 7","key":"10.1016\/j.virol.2023.07.009_bib22","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1099\/0022-1317-76-7-1583","article-title":"Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species","volume":"76","author":"Eloit","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2023.07.009_bib23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/cancers12041034","article-title":"Effect of transgene location, transcriptional control elements and transgene features in armed oncolytic adenoviruses","volume":"12","author":"Farrera-Sal","year":"2020","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.virol.2023.07.009_bib24","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.3390\/ijms21145158","article-title":"Arming oncolytic adenoviruses: effect of insertion site and splice acceptor on transgene expression and viral fitness","volume":"21","author":"Farrera-Sal","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.virol.2023.07.009_bib25","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1002\/1873-3468.13691","article-title":"State-of-the-art human adenovirus vectorology for therapeutic approaches","volume":"593","author":"Gao","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virol.2023.07.009_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jviromet.2014.08.013","article-title":"Establishment and validation of new complementing cells for production of E1-deleted adenovirus vectors in serum-free suspension culture","volume":"208","author":"Gilbert","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2023.07.009_bib27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s12033-013-9653-9","article-title":"Expression of human rotavirus chimeric fusion proteins from replicating but non disseminating adenovectors and elicitation of rotavirus-specific immune responses in mice","volume":"54","author":"Girard","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.virol.2023.07.009_bib28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12033-013-9723-z","article-title":"Flagellin in fusion with human rotavirus structural proteins exerts an adjuvant effect when delivered with replicating but non-disseminating adenovectors through the intrarectal route","volume":"56","author":"Girard","year":"2014","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.virol.2023.07.009_bib29","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1002\/jcp.27850","article-title":"Oncolytic adenovirus: a tool for cancer therapy in combination with other therapeutic approaches","volume":"234","author":"Goradel","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.virol.2023.07.009_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.virol.2023.07.009_bib31","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/j.1460-2075.1996.tb00525.x","article-title":"The role of the adenovirus protease on virus entry into cells","volume":"15","author":"Greber","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2023.07.009_bib32","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1016\/j.vaccine.2019.08.079","article-title":"Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen","volume":"37","author":"Haq","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.07.009_bib33","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1128\/jvi.63.6.2605-2615.1989","article-title":"Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection","volume":"63","author":"Huang","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.07.009_bib34","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1073\/pnas.94.6.2587","article-title":"Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression","volume":"94","author":"Ilan","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2023.07.009_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0166-0934(96)02138-6","article-title":"Generation, validation and large scale production of adenoviral recombinants with large inserts such as 6.3 kb human dystrophin cDNA","volume":"64","author":"Jani","year":"1997","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2023.07.009_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/OV.S196403","article-title":"20. Preclinical and clinical development of oncolytic adenovirus for treatment of malignant gliooma","volume":"8","author":"Kiyokawa","year":"2019","journal-title":"Oncolytic Virotherapy"},{"key":"10.1016\/j.virol.2023.07.009_bib37","first-page":"602","article-title":"Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently","volume":"13","author":"Massie","year":"1995","journal-title":"Bio\/Technology"},{"issue":"1\u20133","key":"10.1016\/j.virol.2023.07.009_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1008013211222","article-title":"New adenovirus vectors for protein production and gene transfer","volume":"28","author":"Massie","year":"1998","journal-title":"Cytotechnology"},{"key":"10.1016\/j.virol.2023.07.009_bib39","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1128\/JVI.72.3.2289-2296.1998","article-title":"Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette","volume":"72","author":"Massie","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.07.009_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0168-1702(93)90090-A","article-title":"Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter","volume":"28","author":"Mittal","year":"1993","journal-title":"Virus Res."},{"issue":"13","key":"10.1016\/j.virol.2023.07.009_bib41","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1089\/104303403767740803","article-title":"Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions","volume":"14","author":"Mizuguchi","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virol.2023.07.009_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1472-6750-6-43","article-title":"The cumate gene-switch: a system for regulated expression in mammalian cells","volume":"6","author":"Mullick","year":"2006","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.virol.2023.07.009_bib43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2018.07.006","article-title":"Advances in oncolytic adenovirus therapy for pancreatic cancer","volume":"434","author":"Nattress","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.virol.2023.07.009_bib44","series-title":"Optimization of Adenoviral Vectors for Cancer Suicide Gene Therapy","author":"Nazemi-Moghaddam","year":"2006"},{"key":"10.1016\/j.virol.2023.07.009_bib45","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/10430340050032438","article-title":"Protease deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy","volume":"11","author":"Oualikene","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virol.2023.07.009_bib46","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1128\/JVI.79.16.10200-10209.2005","article-title":"Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies","volume":"79","author":"Peng","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.07.009_bib47","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.copbio.2007.10.010","article-title":"Replicating and non-replicating viral vectors for vaccine development","volume":"18","author":"Robert-Guroff","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.virol.2023.07.009_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1297-9716-44-17","article-title":"Immunogenic and protective properties of GP5 and M structural proteins of porcine reproductive and respiratory syndrome virus expressed from replicating but nondisseminating adenovectors","volume":"44","author":"Roques","year":"2013","journal-title":"Vet. Res."},{"key":"10.1016\/j.virol.2023.07.009_bib49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1099\/0022-1317-70-2-417","article-title":"Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors","volume":"70","author":"Schneider","year":"1989","journal-title":"J. Gen. Virol."},{"issue":"10","key":"10.1016\/j.virol.2023.07.009_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00157-19","article-title":"Adenovirus 5 E1A Interacts with E4orf3 to regulate viral chromatin organization","volume":"93","author":"Soriano","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.07.009_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.virusres.2018.08.012","article-title":"Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: focus on fiber chimerism and mosaicism, hexon and pIX","volume":"257","author":"Stepanenko","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2023.07.009_bib52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/gt.2014.124","article-title":"Preferable sites and orientations of transgene inserted in the adenovirus vector genome: the E3 site may be unfavorable for transgene position","volume":"22","author":"Suzuki","year":"2015","journal-title":"Gene Ther."},{"issue":"10","key":"10.1016\/j.virol.2023.07.009_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076344","article-title":"Effects of the deletion of early region 4 (E4) open reading frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on virus-host cell interaction, transgene expression, and immunogenicity of replicating adenovirus HIV vaccine vectors","volume":"8","author":"Thomas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2023.07.009_bib54","series-title":"The Molecular Repertoire of Adenoviruses","first-page":"227","article-title":"Adenovirus endopeptidase and its role in virus infection","author":"Weber","year":"1995"},{"key":"10.1016\/j.virol.2023.07.009_bib55","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0264-410X(96)00012-6","article-title":"Human adenovirus type 5 vectors expressing rabies glycoprotein","volume":"14","author":"Yarosh","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2023.07.009_bib56","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1089\/104303403766682278","article-title":"Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses","volume":"14","author":"Youil","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virol.2023.07.009_bib57","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/jvh.12856","article-title":"Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens","volume":"25","author":"Young","year":"2018","journal-title":"J. Viral Hepat."},{"issue":"9","key":"10.1016\/j.virol.2023.07.009_bib58","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1073\/pnas.93.9.4513","article-title":"Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy","volume":"93","author":"Zhang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T01:30:29Z","timestamp":1725931829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682223001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":58,"alternative-id":["S0042682223001484"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2023.07.009","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protease-deleted adenovirus as an alternative for replication-competent adenovirus vector","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2023.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}